Visa signs $2.4 billion deal to acquire Israeli anti-fraud firm BioCatch
Visa agreed to buy Tel Aviv-based BioCatch for $2.4 billion, expanding its AI-driven defenses against scams, account takeovers and digital fraud.
Visa recently finalized a $2.4 billion acquisition of Israeli anti-fraud company BioCatch, expanding its cybersecurity, risk-management and payment-security solutions portfolio. BioCatch, operating in over 350 financial institutions across 21 countries, safeguards 760 million users and 1.8 billion devices using AI and machine-learning to analyze more than 3,000 anonymized data points for suspicious activity.
Visa President Andrew Torre emphasized that BioCatch's technology will help clients prevent fraud before payment, aligning with Visa's strategy to prevent cyber threats before they occur and maintain transaction protection during transactions. The acquisition is part of Visa's $13 billion investment in technology and infrastructure over the past five years to safeguard the payments ecosystem.
The deal is expected to close by the end of Visa's fiscal second quarter of 2027, pending regulatory approvals and closing conditions. BioCatch CEO Gadi Mazor highlighted the company's unique ability to distinguish criminals from legitimate users and stressed the importance of real-time insights into customer intent for building trust in digital banking sessions.
Written by urgent.news from Jerusalem Post Tech & Start-Ups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
